Valuation : Edwards Lifesciences Corporation

Market Cap 49.99B 42.98B 40.43B 36.9B 68.86B 4,739B 69.21B 479B 185B 2,422B 188B 184B 7,708B P/E 2026 *
34.3x
P/E 2027 * 26.2x
Enterprise Value 46.35B 39.86B 37.5B 34.22B 63.86B 4,395B 64.19B 444B 172B 2,246B 174B 170B 7,148B EV / Sales 2026 *
6.86x
EV / Sales 2027 * 6.03x
Free-Float
86.96%
Yield 2026 *
-
Yield 2027 * -
1 day-3.54%
1 week-4.43%
Current month-4.44%
1 month-3.34%
3 months+1.01%
6 months+6.22%
Current year+1.72%
1 week 86.39
Extreme 86.39
91.53
1 month 86.39
Extreme 86.39
93.91
Current year 74.66
Extreme 74.66
96.29
1 year 72.3
Extreme 72.3
96.29
3 years 58.93
Extreme 58.93
96.29
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 2023-05-10
Director of Finance/CFO 43 2026-05-28
Chief Tech/Sci/R&D Officer 51 2025-08-31
Director TitleAgeSince
Chairman 69 2024-05-06
Director/Board Member 62 2015-02-09
Director/Board Member 58 2023-05-10
Date Insider Type Main position Quantity % Market Cap. Importance
8/31/26 Sell

Controller/Auditor

-544 0.0001%
8/28/26 Sell

Executive/Senior Manager

-2,644 0.0005%
8/26/26 Sell

Executive/Senior Manager

-1,240 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-3.54%-4.43%+8.12%+17.08% 49.99B
-1.75%+0.42%+23.66%+16.35% 223B
-1.17%-0.82%+3.32%-17.37% 144B
-4.51%-5.17%-25.50%+17.42% 124B
-5.90%-6.45%-58.41%-16.50% 65.19B
-0.32%-2.00%-18.14%-14.56% 50.49B
-2.66%-2.05%+14.61%+28.83% 41.4B
-1.58%-0.72%+30.24%+52.87% 39.59B
-3.28%+1.90%+114.97%+33.28% 31.87B
-3.20%-4.46%-20.90%+49.41% 31.62B
Average -2.08%-2.18%+7.20%+16.68% 80.11B
Weighted average by Cap. -1.48%-1.91%+3.85%+10.30%

Financials

2026 *2027 *
Net sales 6.76B 5.81B 5.47B 4.99B 9.31B 641B 9.36B 64.78B 25.06B 328B 25.38B 24.83B 1,042B 7.43B 6.39B 6.01B 5.48B 10.23B 704B 10.29B 71.2B 27.55B 360B 27.9B 27.29B 1,146B
Net income 1.44B 1.23B 1.16B 1.06B 1.98B 136B 1.99B 13.75B 5.32B 69.54B 5.39B 5.27B 221B 1.9B 1.63B 1.53B 1.4B 2.61B 180B 2.63B 18.18B 7.03B 91.91B 7.12B 6.97B 292B
Net Debt -3.63B -3.12B -2.94B -2.68B -5B -344B -5.03B -34.8B -13.46B -176B -13.63B -13.34B -560B -5.19B -4.47B -4.2B -3.83B -7.16B -492B -7.19B -49.79B -19.26B -252B -19.51B -19.08B -801B
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
26-09-08 $86.72 -3.54% 3,583,538
26-09-04 $89.90 +0.13% 2,635,295
26-09-03 $89.78 -1.15% 1,844,143
26-09-02 $90.82 +0.09% 2,595,780
26-09-01 $90.74 -0.01% 2,539,929
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
86.72USD
Average target price
100.96USD
Spread / Average Target
+16.42%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!